News

Using cfDNA to predict bladder cancer chemo benefit
May 26, 2022
SWOG researchers have used methylation patterns in cell-free DNA from blood samples to predict which patients with muscle-invasive bladder cancer are likely to benefit from neoadjuvant chemo and which patients can safely skip it.
Standing CSF orders had limited impact
May 26, 2022
Adding standing physician orders to electronic record systems did not improve adherence to guidelines for prophylactic prescribing of colony-stimulating factors for febrile neutropenia for patients on high-risk or low-risk chemotherapy.
SWOG Front Line banner
Apr 22, 2022
The iMATCH pilot: immunotherapy comes of age with a master protocol
S1616 results at AACR 2022
Apr 8, 2022
Reversing resistance to PD-1 inhibitors with combination immunotherapy in patients with advanced melanoma
A lung cancer precision medicine trial: Lung-MAP
Mar 31, 2022
The spring 2022 newsletter for Lung-MAP participating sites is now available.